Dr. Jeffrey Ebersole (Dental) co-authored “Salivary Biological Responses to Nonsurgical Periodontal Treatment in Type 2 Diabetics,” which published May 5 in the JDR Clinical & Translational Research journal. The investigation evaluated the predictive capacity of the oral microbiome and host salivary biomarkers specific to treatment outcomes for periodontitis among patients with type 2 diabetes mellitus. The findings support that a panel of salivary features could enhance prediction and earlier therapy decisions at the biological level, thereby opening the door for more precise patient-level management.